Purified mouse dopamine neurons thrive and function after transplantation into brain but require novel glial factors for survival in culture

Molecular and Cellular Neuroscience

Volumn 30, Issue 1, 2005, Pages 108-117

  Donaldson, A E ^a   Marshall, C E ^a   Yang, Ming ^a   Suon, S ^a   Iacovitti, Lorraine ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DOPAMINE; GREEN FLUORESCENT PROTEIN; GROWTH FACTOR; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL; CELL CULTURE; CELL DEATH; CELL FUNCTION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; LOCOMOTION; MESENCEPHALON; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSGENIC MOUSE;

ANIMALS; BRAIN TISSUE TRANSPLANTATION; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; DOPAMINE; FETAL TISSUE TRANSPLANTATION; FLOW CYTOMETRY; GRAFT SURVIVAL; GREEN FLUORESCENT PROTEINS; GROWTH SUBSTANCES; MICE; MICE, TRANSGENIC; NEUROGLIA; NEURONS; PARKINSON DISEASE; RATS; RATS, INBRED F344;

MUS MUSCULUS;

EID: 23644438922     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2005.06.004     Document Type: Article

References (59)

1. P. Akerud, J. Alberch, S. Eketjall, J. Wagner, and E. Arenas Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons J. Neurochem. 73 1999 70 78
2. R.A. Barker, S.B. Dunnett, A. Faissner, and J.W. Fawcett The time course of loss of dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum Exp. Neurol. 141 1996 79 93
3. A. Bilang-Bleuel, F. Revah, P. Colin, I. Locquet, J.J. Robert, J. Mallet, and P. Horellou Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease Proc. Natl. Acad. Sci. U. S. A. 94 1997 8818 8823
4. L.M. Bjorklund, R. Sanchez-Pernaute, S. Chung, T. Anderson, I.Y.C. Chen, K.S.P. McNaught, A.L. Brownell, B.G. Jenkins, C. Wahlestedt, K.S. Kim, and O. Isacson Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinsonian rat model Proc. Natl. Acad. Sci. U. S. A. 99 2002 2344 2349
5. P. Brundin, J. Karlsson, M. Emgard, G.S. Schierle, O. Hansson, A. Petersen, and R.F. Castilho Improving the survival of grafted dopaminergic neurons: a review over current approaches Cell. Transplant. 9 2000 179 195
6. R.E. Burke, M. Antonelli, and D. Sulzer Glial cell line-derived neurotrophic growth factor inhibits apoptotic death of postnatal substantia nigra dopamine neurons in primary culture J. Neurochem. 71 1998 517 525
7. G. Cacalano, I. Farinas, L.C. Wang, K. Hagler, A. Forgie, M. Moore, M. Armanini, H. Phillips, A.M. Ryan, L.F. Reichardt, M. Hynes, A. Davies, and A. Rosenthal GFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidney Neuron 21 1998 53 62
8. D.L. Choi-Lundberg, Q. Lin, T. Schallert, D. Crippens, B.L. Davidson, Y.N. Chang, Y.L. Chiang, J. Qian, L. Bardwaj, and M.C. Bohn Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor Exp. Neurol. 154 1998 261 275
9. E.D. Clarkson, W.M. Zawada, and C.R. Freed GDNF reduces apoptosis in dopaminergic neurons in vitro NeuroReport 1995 145 149
10. B. Connor, D.A. Kozlowski, J.R. Unnerstall, J.D. Elsworth, J.L. Tillerson, T. Schallert, and M.C. Bohn Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration Exp. Neurol. 169 2001 83 95
11. T. Deacon, J. Dinsmore, L.C. Costantini, J. Ratliff, and O. Isacson Blastula-stage stem cells can differentiate into dopaminergic and serotonergic neurons after transplantation Exp. Neurol. 149 1998 28 41
12. X. Du, and L. Iacovitti Synergy between growth factors and neurotransmitters required for catecholamine differentiation in brain neurons J. Neurosci. 15 1995 5420 5427
13. M. Emgard, J. Karlsson, O. Hansson, and P. Brundin Patterns of cell death and dopaminergic neuron survival in intrastriatal nigral grafts Exp. Neurol. 160 1999 279 288
14. H. Enomoto, T. Araki, A. Jackman, R.O. Heuckeroth, W.D. Snider, E.M. Johnson Jr., and J. Milbrandt GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys Neuron 21 1998 317 324
15. E. Fernandez-Espejo Pathogenesis of Parkinson's disease: prospects of neuroprotective and restorative therapies Mol. Neurobiol. 29 2004 15 30
16. R.D. Folkerth, and R. Durso Survival and proliferation of nonneural tissues, with obstruction of cerebral ventricles, in a parkinsonian patient treated with fetal allografts Neurol 46 1996 1219 1225
17. C.R. Freed, P.E. Greene, R.E. Breeze, W.Y. Tsai, W. DuMouchel, R. Kao, S. Dillon, H.S. Winfield Culver, J.Q. Trojanowski, D. Eidelberg, and S. Fahn Transplantation of embryonic dopamine neurons for severe Parkinson's disease N. Engl. J. Med. 344 2001 710 719
18. M.A. Gates, E.D. Laywell, H. Fillmore, and D.A. Steindler Astrocytes and extracellular matrix following intracerebral transplantation of embryonic ventral mesencephalon or lateral ganglionic eminence Neuroscience 74 1996 579 597
19. R. Grondin, Z. Zhang, Y. Ai, D.M. Gash, and G.A. Gerhardt Intracranial delivery of proteins and peptides as a therapy for neurodegenerative diseases Prog. Drug Res. 61 2003 101 123
20. B.A. Horger, M.C. Nishimura, M.P. Armanini, L.C. Wang, K.T. Poulsen, C. Rosenblad, D. Kirik, B. Moffat, L. Simmons, E. Johnson Jr., J. Milbrandt, A. Rosenthal, A. Bjorklund, R.A. Vandlen, M.A. Hynes, and H.S. Phillips Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons J. Neurosci. 18 1998 4929 4937
21. D.Y. Hwang, P. Ardayfio, U.J. Kang, E.V. Semina, and K.S. Kim Selective loss of dopaminergic neurons in the substantia nigra of Pitx3-deficient aphakia mice Brain Res. Mol. Brain Res. 114 2003 123 131
22. L. Iacovitti, and N.D. Stull Induction of tyrosine hydroxylase in hNT neurons NeuroReport 8 1997 1471 1474
23. L. Iacovitti, N.D. Stull, and A. Mishizen Neurotransmitters, KCl and antioxidants rescue striatal neurons from apoptotic cell death in culture Brain Res. 816 1999 276 285
24. L. Iacovitti, N.D. Stull, and H. Jin Differentiation of human dopamine neurons from an embryonic carcinomal stem cell line Brain Res. 912 2001 99 104
25. V. Jackson-Lewis, M. Vila, R. Djaldetti, C. Guegan, G. Liberatore, J. Liu, K.L. O'Malley, R.E. Burke, and S. Przedborski Developmental cell death in dopaminergic neurons of the substantia nigra of mice J. Comp. Neurol. 424 2000 476 488
26. B.K. Jin, and L. Iacovitti Dopamine differentiation factors produce partial motor recovery in 6-hydroxydopamine lesioned rats Neurobiol. Dis. 2 1995 1 12
27. H. Kawasaki, K. Mizuseki, S. Nishikawa, S. Kaneko, Y. Kuwana, S. Nakanishi, S.I. Nishikawa, and Y. Sasai Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity Neuron 28 2000 31 40
28. M.A. Kessler, M. Yang, K.L. Gollomp, H. Jin, and L. Iacovitti The human tyrosine hydroxylase promoter Mol. Brain Res. 112 2003 8 23
29. N. Kholodilov, O. Yarygina, T.F. Oo, H. Zhang, D. Sulzer, W. Dauer, and R.E. Burke Regulation of the development of mesencephalic dopaminergic systems by the selective expression of glial cell line-derived neurotrophic factor in their targets J. Neurosci. 24 2004 3136 3146
30. J.H. Kim, J.M. Auerbach, J.A. Rodriguez-Gomez, I. Velasco, D. Gavin, N. Lumelsky, S.H. Lee, J. Nguyen, R. Sanchez-Pernaute, K. Bankiewicz, and R. McKay Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease Nature 418 2002 50 56
31. J.H. Kordower, T.B. Freeman, B.J. Snow, F.J.G. Vingerhoets, E.J. Mufson, P.R. Sanberg, R.A. Hauser, D.A. Smith, G.M. Nauert, D.P. Perl, and W.C. Olanow Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease N. Engl. J. Med. 332 1995 1118 1124
32. K. Krieglstein, P. Henheik, L. Farkas, J. Jaszai, D. Galter, K. Krohn, and K. Unsicker Glial cell line-derived neurotrophic factor requires transforming growth factor-beta for exerting its full neurotrophic potential on peripheral and CNS neurons J. Neurosci. 18 1998 9822 9834
33. K. Krieglstein, J. Strelau, A. Schober, A. Sullivan, and K. Unsicker TGF-beta and the regulation of neuron survival and death J. Physiol. 96 2002 25 30
34. S.H. Lee, N. Lumelsky, L. Studer, J.M. Auerbach, and R.D. McKay Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells Nat. Biotechnol. 18 2000 675 679
35. L.F. Lin, D.H. Doharty, J.D. Lile, S. Bektesh, and F. Collins GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons Science 260 1993 1130 1132
36. D.K. McCarthy, and J. de Vellis Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue J. Cell Biol. 85 1980 890 902
37. J. Mokry Experimental models and behavioural tests used in the study of Parkinson's disease Physiol. Res. 44 1995 143 150
38. M.W. Moore, R.D. Klein, I. Farinas, H. Sauer, M. Armanini, H. Phillips, L.F. Reichardt, A.M. Ryan, K. Carver-Moore, and A. Rosenthal Renal and neuronal abnormalities in mice lacking GDNF Nature 382 1996 76 79
39. T. Nagatsu, M. Mogi, H. Ichinose, and A. Togari Changes in cytokines and neurotrophins in Parkinson's disease J. Neural Transm., Suppl. 60 2000 277 290
40. L. Olsin The coming of age of the GDNF family and its receptors: gene delivery in a rat Parkinson model may have clinical implications Trends Neurosci. 20 1997 277 279
41. T.F. Oo, N. Kholodilov, and R.E. Burke Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal glial cell line-derived neurotrophic factor in vivo J. Neurosci. 23 2003 5141 5148
42. S. Park, K.S. Lee, Y.J. Lee, H.A. Shin, H.Y. Cho, K.C. Wang, Y.S. Kim, H.T. Lee, K.S. Chung, E.Y. Kim, and J. Lim Generation of dopaminergic neurons in vitro from human embryonic stem cells treated with neurotrophic factors Neurosci. Lett. 359 2004 99 103
43. T. Reum, F. Olshausen, T. Mazel, I. Vorisek, R. Morgenstern, and E. Sykova Diffusion parameters in the striatum of rats with 6-hydroxydopamine- induced lesions and with fetal mesencephalic grafts J. Neurosci. Res. 70 2002 680 693
44. E. Roussa, and K. Krieglstein Induction and specification of midbrain dopaminergic cells: focus on SHH, FGF8, and TGF-beta Cell Tissue Res. 318 2004 23 33
45. A. Rousselet, L. Fetler, B. Chamak, and A. Prochiantz Rat mesencephalic neurons in culture exhibit different morphological traits in the presence of media conditioned on mesencephalic or striatal astroglia Dev. Biol. 129 1988 495 504
46. M.P. Sanchez, I. Silos-Santiago, J. Frisen, B. He, S.A. Lira, and M. Barbacid Renal agenesis and the absence of enteric neurons in mice lacking GDNF Nature 382 1996 70 73
47. K. Sawamoto, N. Nakao, K. Kobayashi, N. Matsushita, H. Takahashi, K. Kakishita, A. Yamamoto, T. Yoshizaki, T. Terashima, F. Murakami, T. Itakura, and H. Okano Visualization, direct isolation, and transplantation of midbrain dopaminergic neurons Proc. Natl. Acad. Sci. U. S. A. 98 2001 6423 6428
48. M.K. Schulz, L. Schnell, A.J. Castro, M.E. Schwab, and G.L. Kartje Cholinergic innervation of fetal neocortical transplants is increased after neutralization of myelin-associated neurite growth inhibitors Exp. Neurol. 149 1998 390 397
49. T.C. Schulz, G.M. Palmarinin, S.A. Noggle, D.A. Weiler, M.M. Mitalipova, and B.G. Condie Directed neuronal differentiation of human embryonic stem cells BMC Neurosci. 4 2003 27 40
50. M.E. Schwab Molecules inhibiting neurite growth: a minireview Neurochem. Res. 21 1996 755 761
51. C.E. Sortwell, B.F. Daley, M.R. Pitzer, and T.J. Collier Time course of apoptotic cell death within mesencephalic cell suspension grafts: implications for improving grafted dopamine neuron survival Exp. Neurol. 165 2000 268 277
52. N.D. Stull, D.L. Polan, and L. Iacovitti Antioxidants protect dopamine neurons and their terminals from toxin induced destruction in vivo and in vitro Brain Res. 931 2002 181 185
53. S. Suon, H. Jin, A.E. Donaldson, E.J. Caterson, R.S. Tuan, G. Deschennes, C. Marshall, and L. Iacovitti Adult human bone marrow stem cells transiently differentiate in culture to express CNS proteins Stem Cells Dev. 13 2004 625 635
54. P. Teismann, and J.B. Schulz Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation Cell Tissue Res. 318 2004 149 161
55. C.T. Trott, S. Fahn, P. Greene, S. Dillon, H. Winfield, L. Winfield, R. Kao, D. Eidelberg, C.R. Freed, R.E. Breeze, and Y. Stern Cognition following bilateral implants of embryonic dopamine neurons in PD: a double blind study Neurol 60 2003 1938 1943
56. M. Yang, E.Y. Snyder, N.D. Stull, M. Berk, and L. Iacovitti Neuronal stem cells spontaneously differentiate into dopaminergic neurons after transplantation into the intact or 6-hydroxydopamine lesioned rat Exp. Neurol. 177 2002 50 60
57. M. Yang, A.E. Donaldson, Y. Jiang, and L. Iacovitti Factors influencing the differentiation of dopaminergic traits in transplanted neural stem cells Mol. Cell. Neurobiol. 23 2003 851 864
58. M. Yang, A.E. Donaldson, C.E. Marshall, J. Shen, and L. Iacovitti Studies on the differentiation of dopaminergic traits in human progenitor cells in vitro and in vivo Cell. Transplant. l13 2004 535 547
59. M. Zoli, C. Torri, R. Ferrari, A. Jansson, I. Zini, K. Fuxe, and L.F. Agnati The emergence of the volume transmission concept Brain Res. Rev. 26 1998 136 147